Tesamorelin, CJC-1295 (No DAC), Ipamorelin 12mg (Blend)

Two GHRH Analogs. One Clean GHRP. The Ultimate Amplification Stack.

ipamorelin vs sermorelin You’ve researched growth hormone secretagogues. You know that GHRH analogs and GHRPs work synergistically. But what if you could amplify GH release through two different GHRH pathways simultaneously?

Enter the Tesamorelin, CJC-1295 (No DAC), Ipamorelin 12mg (Blend) .

This is not a beginner’s blend. This is for advanced researchers who understand that different GHRH analogs have different receptor binding kinetics, half-lives, and research histories.

• Tesamorelin — A potent GHRH analog with a unique research profile, studied extensively for metabolic applications

• CJC-1295 (No DAC) — A modified GRF analog with optimized stability and ~30-minute half-life

• Ipamorelin — The cleanest GHRP available — no prolactin, no cortisol, no appetite stimulation

Three peptides. Two GHRH pathways. One clean GHRP. One vial.

Let’s break down the peptide science behind this sophisticated triple blend.

---

What’s Actually in the Vial?

Straight facts. No mystery fillers.

Lyophilized powder. Sterile. ≥99% purity for all three peptides. Third-party tested. Vacuum-sealed amber glass vial.

Three peptides. One vial. Balanced triple ratio.

That’s advanced peptide science.

---

Why Two GHRH Analogs? (The Enthusiast Take)

You might be thinking: “Why two GHRH analogs? Don’t they do the same thing?”

Great question. Here’s why combining Tesamorelin and CJC-1295 (No DAC) creates something unique.

Tesamorelin is a potent GHRH analog with a specific research history. It has a slightly different structure than native GHRH, designed for enhanced potency and stability. Its half-life is approximately 60-90 minutes — longer than Sermorelin but shorter than CJC with DAC.

CJC-1295 (No DAC) is a modified GRF analog optimized for stability without the DAC extension. Its half-life is approximately 30 minutes. It’s one of the most studied GHRH analogs in research.

Ipamorelin is the cleanest GHRP available — no prolactin, no cortisol, no appetite stimulation. It provides prolonged GH release (60-90 minutes) without side effect confounders.

Together, the two GHRH analogs:

• Bind to the same GHRH receptors but with different kinetics

• May activate complementary signaling pathways

• Provide a broader temporal profile of GH amplification

• Reduce the risk of receptor desensitization compared to high-dose single analog

Why both instead of one at double dose?
Receptor pharmacology suggests that combining two different GHRH analogs with distinct binding kinetics may produce more physiological GH amplification than simply increasing the dose of one analog. This is the kind of nuanced peptide science that this blend enables.

That’s not speculation. That’s advanced peptide science.

---

The Technical Expert Breakdown (Still Friendly)

For those who want mechanisms without the lecture:

Tesamorelin – Potent GHRH analog

• Synthetic GHRH analog with enhanced stability

• Binds to GHRH receptors on pituitary somatotrophs

• Potently stimulates GH release (not just amplification)

• Half-life: ~60-90 minutes

• Unique research history in metabolic applications

• Different structure than native GHRH for improved pharmacokinetics

CJC-1295 (No DAC) – Modified GRF analog

• Modified GRF (Growth Hormone Releasing Factor) without Drug Affinity Complex

• Binds to same GHRH receptors with high affinity

• Amplifies pulsatile GH release

• No DAC = ~30-minute half-life → clean pulsatile return to baseline

• Modified amino acid sequence for stability against enzymatic degradation

Ipamorelin – Third-generation GHRP

• Binds to ghrelin (GHS-R1a) receptors with high selectivity

• Potent GH release without significant prolactin elevation

• No clinically significant cortisol increase

• No appetite stimulation

• Peak GH release within 30-40 minutes

• Prolonged GH duration (60-90 minutes)

Dual GHRH analog synergy:
Tesamorelin and CJC-1295 both bind to GHRH receptors but with:

• Different affinities

• Different half-lives

• Different molecular structures

This dual activation may produce more robust GH amplification than either analog alone, while the shorter half-life of CJC-1295 ensures clean return to baseline between pulses.

Ipamorelin contribution:
Provides clean GH initiation without confounding side effects, allowing researchers to isolate GHRH analog effects from GHRP variables.

That’s the kind of sophisticated peptide science that advanced research protocols demand.

---

Tesamorelin vs. CJC-1295 (No DAC): Comparison

Together, they provide complementary pharmacokinetic profiles.

---

Why Ipamorelin Instead of Other GHRPs?

For clean data with dual GHRH analogs, Ipamorelin is the logical choice — it adds no confounding variables.

---

Reconstitution & Dosing (Laid-Back Version)

Simple. Clean. Precision matters with three peptides.

What you need:

• Bacteriostatic water

• Insulin syringe (0.5ml or 1ml, 30–31 gauge)

• Alcohol wipes

Quick math:

Add 2ml of bacteriostatic water to the vial.

Now each 0.1ml (10 units on a 1ml syringe) contains:
→ ~200mcg Tesamorelin
→ ~200mcg CJC-1295 (No DAC)
→ ~200mcg Ipamorelin

Alternative: Lower concentration for finer dosing

Add 3ml of bacteriostatic water instead.

Each 0.1ml (10 units) then contains:
→ ~133mcg of each peptide

Common dosing for research protocols (using 2ml reconstitution):

Best practice for this blend:

Administer on an empty stomach (at least 2 hours after eating, 30 minutes before). GH release is suppressed by glucose and insulin.

Timing protocols:

• Morning: Upon waking, before breakfast

• Post-workout: After training, before eating

• Bedtime: 30-60 minutes before sleep

Note: The dual GHRH analogs provide amplification across a broader time window than single analogs. Twice-daily protocols are common in advanced research.

Store in refrigerator after reconstitution. Use within 30 days.

Reminder: This information is for educational and research purposes only. Always follow institutional guidelines.

---

Who Is This Triple Blend For?

• Advanced researchers studying GHRH analog combinations

• Comparative studies examining Tesamorelin vs. CJC-1295

• Labs interested in dual-pathway GH amplification

• Metabolism researchers familiar with Tesamorelin’s research history

• Any study requiring clean GH data (Ipamorelin ensures no side effect confounders)

• Researchers who want the broadest possible GH amplification profile

This blend is not for:

• First-time peptide researchers (start with single peptides or two-peptide blends)

• Studies requiring zero GH elevation (use placebo)

• Budget-constrained research (this is a premium blend)

---

Triple Blend vs. Two-Peptide Options: Comparison

The triple blend offers dual GHRH amplification — a unique research tool.

---

What About Purity and Testing?

Triple the peptides means triple the testing.

Every batch of the Tesamorelin, CJC-1295 (No DAC), Ipamorelin 12mg (Blend) is tested by an independent, ISO-certified lab. You receive:

• HPLC purity report (≥99% for each of the three peptides)

• Mass spectrometry confirmation for all three

• Endotoxin and bioburden testing

• Amino acid analysis for each peptide

A scannable QR code on each vial links directly to batch-specific data.

That’s real peptide science transparency.

---

Storage & Handling

Allow vial to reach room temperature before adding bacteriostatic water. Swirl gently for 60-90 seconds.

---

Frequently Asked Questions

Why combine two GHRH analogs?
Tesamorelin and CJC-1295 (No DAC) bind to the same GHRH receptors but with different kinetics and half-lives. Dual activation may produce more robust GH amplification than either alone, with a broader temporal profile. sermorelin and ipamorelin

What is Tesamorelin known for in research?
Tesamorelin has a unique research history, particularly in metabolic studies. Its structure is optimized for potency and stability, with a longer half-life (~60-90 minutes) than Sermorelin or unmodified GRF.

How is CJC-1295 (No DAC) different from Tesamorelin?
CJC-1295 (No DAC) is a modified GRF analog with a ~30-minute half-life. It’s optimized for stability against enzymatic degradation. Together, they provide complementary pharmacokinetic profiles.

Why Ipamorelin instead of GHRP-2 or GHRP-6?
Ipamorelin has no prolactin, cortisol, or appetite effects. When studying dual GHRH analogs, adding a GHRP with side effects would introduce confounding variables. Ipamorelin keeps the data clean.

How long does one 12mg vial last?
>At 100mcg of each, once daily: ~40 days.
>At 100mcg of each, twice daily: ~20 days.
>At 150mcg of each, once daily: ~26 days.
>At 200mcg of each, once daily: ~20 days.

Why empty stomach?
Glucose and insulin suppress GH release. Fasting is essential for consistent GH research results.

Is this blend more expensive than single GHRH blends?
Yes. This is a premium research tool for advanced protocols. The dual GHRH approach is not necessary for most research — it’s for specific applications where maximum amplification is required. sermorelin and ipamorelin

---

Research Applications Summary

---

The Bottom Line

You’re an advanced researcher. You understand that peptide science is about choosing the right combination of tools for your specific research question.

The Tesamorelin, CJC-1295 (No DAC), Ipamorelin 12mg (Blend) gives you:

• Three complementary peptides in one vial

• Precise 1:1:1 ratio (4mg each)

• ≥99% purity, third-party tested for all three

• Tesamorelin — potent GHRH analog with ~60-90 minute half-life

• CJC-1295 (No DAC) — modified GRF analog with ~30-minute half-life

• Ipamorelin — cleanest GHRP available — no side effects

• Dual GHRH amplification + clean GHRP initiation

This is not a beginner’s blend. This is for researchers who want to study dual GHRH analog synergy, compare Tesamorelin and CJC-1295 in the same protocol, or achieve maximum GH amplification without confounding side effects.

Research smart. Amplify with dual pathways. Keep your data clean.

---

This product is intended for laboratory research and scientific study purposes only. Not for human consumption or veterinary use outside of approved research protocols. Always comply with local regulations regarding peptide research.